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Abstract
Introduction: The objective of this study was to identify trends in requests for anti-thyroid peroxidase antibodies (TPOab) and anti-thyroglobulin 
antibodies (TGab) tests before and after applying set of interventions based on rejection rules and profile management.
Materials and methods: Trend analysis was made at semester time intervals (from May-October 2010 to May-October 2017), before and after 
the intervention semester (May-October 2016). Number of tests (N) TPOab and TGab / 1000 total requests based on total N of both tests and total 
N of biochemical analysis laboratory requests, was calculated. To find out where the interventions had more impact we distinguished N of requests 
between Primary Care (PC) and Specialized Care (SC). A joinpoint regression analysis was used to determine time segments and time points in these 
indicators where the trend changed.  
Results: Trend analysis of the request of TPOab and TGab showed two clearly differentiated trend lines with a statistically significant Joinpoint (P 
< 0.001) with an increase in each semester from May 2010 of 7.4% and 7.5% respectively, to the semester of the interventions where there was a 
decrease of - 45% and - 61% located mainly in PC. Trend analysis in SC setting did not show any Joinpoint and any trend line.
Conclusions: Results showed that applied interventions enabled change of trend for TPOab and TGab test requests, especially in PC where the in-
terventions proved to be the most successful.
Keywords: demand management laboratory; test laboratory request; anti-thyroid antibodies; anti-thyroid peroxidase antibodies; anti-thyroglobu-
lin antibodies
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Introduction
Clinical decisions are mainly based on laboratory 
test results, and it is essential to keep demand for 
tests under control. Establishing strategies to en-
sure that the amount of requests for laboratory 
tests is appropriate should be a transversal meas-
ure proper to good management of any health 
centre (1).
A request for laboratory test could be considered 
“inappropriate” when it is not based on any scien-
tific evidence. There are two possible situations: ei-
ther the test is not justified by the given diagnosis 
or the clinical situation; and/or the time interval of 
a new request following a previous one is not suit-
able (2-4). This can result in additional and unnec-
essary costs. It is also recognized that test request-
ing varies significantly between different coun-
tries, regions and even among doctors belonging 
to the same hospital or service (5). An appropriate 
and timely requirement for a laboratory test im-
proves quality and efficiency of healthcare. There-
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fore, it is necessary to carry out a trend analysis of 
requests over the years, verify if there is an in-
crease in requests, analyse the causes, apply meas-
ures to adjust the numbers, and check the success 
of these interventions (6).
The determination of anti-thyroid antibodies, anti-
thyroid peroxidase antibodies (TPOab) and anti-
thyroglobulin antibodies (TGab), has widespread 
clinical use: autoimmune thyroid disease is among 
the most prevalent autoimmune diseases and the 
object of a large number of consultations both in 
Endocrinology and in the Primary Care (PC). The 
semiological values of these antibodies in thyroid 
autoimmune disease and in thyroid cancer have 
been included in clinical guidelines for some time, 
but demand for them varies greatly in routine 
medical practice (7). This can be due to multiple 
causes, for example opening the requests to non-
endocrinologists such as internists and PC physi-
cians (8). The objective of this study was to identify 
trends in requests for TPOab and TGab tests be-
fore and after applying set of interventions based 
on rejection rules and profile management.
Materials and methods
Study design
The study was conducted at the University Hospi-
tal of Vinalopó (Elche, Spain) from May 2010 to Oc-
tober 2017. This hospital has 200 beds and serves a 
population of about 150,000 inhabitants. The lab-
oratory provides biochemical analysis and micro-
biology services. It is open 24 hours a day during 
which it ensures its complete range of services, 
which are not restricted to emergencies only. 
The University Hospital of Vinalopó is equipped by 
information system and Electronic Health Records 
are used. The principle of test requesting in the 
hospital is that a search of particular laboratory 
tests by doctors could be made through hospital 
information system. Tests for TPOab and TGab 
could be requested separately as well as through 
the profiles named “Endocrine-Special Tests” and 
“Thyroid Cancer Study” respectively that was con-
sisted of special non-routine tests for the study of 
endocrine pathology. All doctors from PC and 
Specialized Care (SC) have access and could re-
quest all laboratory tests from the catalogue 
through the hospital information system.
Requests for TPOab and TGab tests in period from 
May 2010 to October 2017 were collected from 
laboratory information system. In period from May 
2010 to October 2017 number (N) of requests was 
observed through the semesters (periods from 
May-October and November-April) for each year 
of study. The period of May-October 2016 was de-
fined as semester of interventions when we ap-
plied set of specific interventions.
1. In May 2016, an association of the TPOab and 
TGab tests, named anti-thyroid antibodies, was re-
moved from the catalogue, so both had to be re-
quested separately rather than simultaneously as 
before.
2. In October 2016, the profiles under which these 
tests appeared were restructured; TPOab test were 
included under the profile corresponding to spe-
cial endocrinology tests, and TGab under the pro-
file corresponding to study of differentiated thy-
roid cancer next to thyroglobulin. Furthermore, 
three rejection rules applied for test ordering:
a. TPOab: If a previous positive result has been 
found, the comment “POSITIVE result in previous 
analysis, determination is irrelevant since it is NOT 
useful in monitoring autoimmune thyroid disease” 
appears and the request is not processed (rejec-
tion rule 1).
b. TGab: Except in the case of thyroid cancer, if this 
test is requested together with the TPOab test, 
and the latter is positive, the following comment 
appears: “This test will not be performed since the 
determination of TGab does not provide any new 
information to detect autoimmune thyroid dis-
ease with respect to the POSITIVE TPOab” (rejec-
tion rule 2). 
c. If both tests are requested together for the first 
time and the TPOab is positive, they are not per-
formed either and the same comment appears (re-
jection rule 3). Thus, the test is only carried out if 
the TPOab test is negative. A separate comment is 
given in the case of diagnosis and monitoring of 
thyroid cancer, in which case the tests are per-
formed in all cases. 
https://doi.org/10.11613/BM.2018.030709 Biochem Med (Zagreb) 2018;28(3):030709 
  3
Sánchez Pellicer P. et al. Reducing request for anti-thyroid antibodies
The indicators that we use to monitor the demand 
and conduct a trend analysis study before and af-
ter these specific interventions in TPOab and TGab 
tests were the following:
•	 N tests TPOab and TGab / 1000 total requests 
(TR) (TPOab / 1000 TR and TGab / 1000 TR) 
based on total N of both tests for numerator 
and total N of biochemical analysis laboratory 
requests for denominator. 
•	 N tests TPOab and TGab / 1000 PC requests 
(PCR) (TPOab / 1000 PCR and TGab / 1000 PCR) 
based on total N of both tests requested from 
PC for numerator and total N of biochemical 
analysis laboratory requests requested from PC 
for denominator.
•	 N tests TPOab and TGab / 1000 SC requests 
(SCR) (TPOab / 1000 SCR and TGab / 1000 SCR) 
based on total N of both tests requested from 
SC for numerator and total N of biochemical 
analysis laboratory requests requested from SC 
for denominator.
•	 Ratio TGab / TPOab total tests based on total N 
of both tests. 
The indicator TPOab and TGab / 1000 TR will allow 
us to show the evolution of the global request of 
these tests and to verify if the measures were ef-
fective. TPOab and TGab / 1000 PCR and TPOab 
and TGab / 1000 SCR will allow us to assess where 
interventions have had more impact, SC or PC. Ra-
tio TPOab / TGab total tests is an indicator of 
achieved objective to assess the success of inter-
ventions. If result is equal to 1 it means that tests 
are requested simultaneously.
Statistical analysis 
To determine trend of TPOab and TGab requests 
the specific indicators were used and joinpoint re-
gression was performed for the each studied se-
mester. Joinpoint regression is a statistical model-
ling technique that explains the relationship be-
tween two variables by means of a segmented lin-
ear regression constrained to be continuous eve-
rywhere, in particular in those places where the 
slope of the regression function changes. It is com-
posed of a few continuous linear phases; line seg-
ments are joined at points called Joinpoints (9). 
Each Joinpoint shows a significant change in trend 
statistically significant (P < 0.05), and a Semester 
Percentage of Change (SPC) of indicators used in 
study with the corresponding 95% confidence in-
terval (95% CI). The SPC were proposed to summa-
rize and compare the rates of changes that are not 
constant over a given time period and shows the 
percentage (%) of change for each indicator in 
each trend line. A negative value (upper CI is nega-
tive) of SPC indicated a decreasing trend, whereas 
a positive value (lower CI is positive) of SPC indi-
cated an increasing trend. A SPC was calculated by 
logarithmic transformation. It is usual assumption 
that the indicators were normally distributed, be-
cause the high numbers of numerators and de-
nominators of indicators, and heteroscedastic vari-
ances for this. Montecarlo permutation test was 
used to prove the existence of Joinpoints. This 
permutation test is used for testing between two 
different joinpoint models, a simpler model with 
fewer Joinpoints called the null model, and a more 
complicated model called the alternative model 
(9).
Notably, the presence of one Joinpoint would im-
ply two SPC, one before and one after, with two 
trend lines. The presence of any Joinpoint may or 
may not imply a single SPC: there will be one SPC if 
it is statistically significant from zero at the alpha 
level = 0.05.
In order to build the model, we used the free Join-
point Regression Program Version 4.5.0.1 (National 
Cancer Institute, 2017).
Results
In the semester previous to interventions, globally 
request for TPOab and TGab tests was 2347 and 
2525 to decrease until 693 and 352, respectively, in 
last semester of study (Figure 1). 
Global request for anti-thyroid antibodies tests, 
measured as TPOab / 1000 TR and TGab / 1000 TR, 
presented two clearly differentiated trend lines 
with a statistically significant Joinpoint (P < 0.001) 
in the semester of May to October 2016, that was 
semester of interventions. First segment present-
ed an SPC of 7.4% (CI 95%: 9.8 to 5.1%) and 7.5% (CI 
Biochem Med (Zagreb) 2018;28(3):030709  https://doi.org/10.11613/BM.2018.030709 
4
Sánchez Pellicer P. et al. Reducing request for anti-thyroid antibodies
95%: 9.9 to 5.2%) for TPOab / 1000 TR and TGab / 
1000 TR, respectively, and showing an increase in 
request of both tests since the opening of the hos-
pital (May 2010). Second segment presented an 
SPC of - 45% (CI 95%: - 63 to - 19%) and - 61% (CI 
95%: - 80 to 20%) respectively, and representing a 
decrease beginning with the start of interventions 
in May 2016 (Table 1). Notably, request was similar 
for both tests, almost exactly equal over the same 
period until semester of interventions; in fact, 
TGab / TPOab total tests was 1 until reaching Join-
point revealing the change in trend. In last semes-
ter of study decreased until 0.4, a more appropri-
ate number. 
In the semester previous to interventions PC re-
quest for both tests was 1840 to decrease until 396 
TPOab tests and 161 TGab tests in last semester of 
study. 
We find that in PC with TPOab / 1000 PCR and 
TGab / 1000 PCR indicators; also, there were two 
clearly differentiated trend lines with a statistically 
significant Joinpoint (P < 0.001) in both tests in the 
semester of interventions. First segment present-
ed an SPC of 12.1% (CI 95%: 15.5 to 8.8%) for TPOab 
and 11.7% (CI 95%: 15.1 to 8.4%) for TGab, showing 
an increase in request since 2010. Second segment 
presented an SPC of - 58% (CI 95%: - 77 to - 24%) 
and - 70% (CI 95%: - 87 to - 29%) respectively, rep-
resenting a decrease in PC in request for these 
tests (Table 2). Number of requested tests from PC 
decreased since semester of interventions as 
shown in Figure 1. 
In SC setting Joinpoint was not found. Therefore, 
there was no trend line and any trend change in 
TPOab and TGab test request because both SPCs 
were not statistically significant from zero at the 
alpha level = 0.05. Despite intervention, N of re-
quested tests from SC remain at the same level as 
shown in Figure 1. 
Rejection rule designed for TPOab test produced a 
rejection rate of 16% since its implementation. The 
rest of the reduction was due to modifications to 
the profiles. In case of TGab tests our 2 rejection 
rules designed generated a 17% rejection rate 
since its implementation. Rest of the reduction 
was attributed to fact of categorizing the test un-
der a specific profile for the study of differentiated 
thyroid cancer with thyroglobulin.
Figure 1. Number of antithyroid antibody test requests from May-October 2010 to May-October 2017. 
We represent in the vertical axis the number of anti-thyroid peroxidase antibodies (TPOab) and anti-thyroglobulin antibodies (TGab) 
tests from global, primary care and specialized care, and in the horizontal axis the semesters of study. 
N Total TPOab - total number of TPOab tests requested globally. N Total TGab - total number of TGab tests requested globally. 
N SC TPOab - number of TPOab tests requested from Specialized Care. N SC TGab - number of TGab tests requested from Specialized 
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Semester of study TPOab / 1000 TR SPC of trend line TPOab / 1000 TR TGab / 1000 TR
SPC of trend line TGab / 
1000 TR
May - October 2010 8.1
7.4%
(CI 95%: 9.8 to 5.1%)
8.1
7.5%
(CI 95%: 9.9 to 5.2%)
November 2010 - April 2011 7.4 7.4
May - October 2011 10.6 10.5
November 2011 - April 2012 14.0 14.0
May - October 2012 12.5 12.5
November 2012 - April 2013 10.8 10.8
May - October 2013 12.6 12.6
November 2013 - April 2014 15.0 15.0
May - October 2014 15.5 15.5
November 2014 - April 2015 17.0 17.0
May - October 2015 19.4 19.1
November 2015 - April 2016 20.0 21.5
May - October 2016 18.8
- 45%
(CI 95%: - 63 to - 19%)
17.6
- 61%
(CI 95%: - 80 to 20%)November 2016 - April 2017 12.1 8.6
May - October 2017 6.0 3.0
TPOab - anti-thyroid peroxidase antibodies. TGab - and anti-thyroglobulin antibodies. Results are presented as number of TPOab 
and TGab tests per 1000 of total requests through semesters from May 2010 to October 2017. Semester of interventions was 
May-October 2016. By joinpoint regression two lines of trend along with 2 SPS for both specific indicators were obtained. TR - total 
requests. SPC - semester percentage of change.
Table 1. Trend analysis of number of anti-thyroid peroxidase antibodies and anti-thyroglobulin antibodies tests per 1000 of total re-
quests
Semester of study TPOab / 1000 PCR SPC trend line TPOab / 1000 PCR TGab / 1000 PCR
SPC trend line TGab / 
1000 PCR
May - October 2010 9.6
12.1%
(CI 95%: 15.5 to 8.8%)
9.6
11.7%
(CI 95%: 15.1 to 8.4%)
November 2010 - April 2011 7.8 7.8
May - October 2011 12.4 12.4
November 2011 - April 2012 21.0 21.0
May - October 2012 20.5 20.5
November 2012 - April 2013 19.1 19.1
May - October 2013 24.3 24.3
November 2013 - April 2014 32.4 32.4
May - October 2014 33,0 33.0
November 2014 - April 2015 35.9 35.9
May - October 2015 41.2 39.3
November 2015 - April 2016 41.8
- 58%
(CI 95%: - 77 to - 24%)
41.8
- 70%
(CI 95%: - 87 to 29%)
May - October 2016 39.2 37.0
November 2016 - April 2017 18.4 15.0
May - October 2017 9.3 3.8
TPOab - anti-thyroid peroxidase antibodies. TGab - and anti-thyroglobulin antibodies. Results are presented as number of TPOab 
and TGab tests per 1000 of primary care requests through semesters from May 2010 to October 2017. Semester of interventions 
was May-October 2016. By joinpoint regression two lines of trend along with 2 SPS for both specific indicators were obtained. PCR - 
primary care requests. SPC - semester percentage of change. 
Table 2. Trend analysis of number of anti-thyroid peroxidase antibodies and anti-thyroglobulin antibodies tests per 1000 of primary 
care requests
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Discussion
Results obtained showed a significant global de-
crease in both TPOab and TGab tests after apply-
ing set of interventions based on rejection rules 
and profile management that began in the semes-
ter of May to October 2016. The intervention ap-
plied, was successful in PC, whereas no change in 
trend was obtained in SC.
In the study of Salinas et al. obtained ratio of TGab 
/ TPOab total tests median was 0.7, based on data 
from 110 Laboratories in Spain in 2014 (8). It was an 
observational study, and we do not know if in each 
of these laboratories any interventions were ap-
plied to manage request for TPOab and TGab 
tests. In our study, ratio TGab / TPOab total tests 
was quite below this observed median in the peri-
od post intervention. Thus, the department re-
quests a relatively low number of tests, compared 
to other regions of Spain, and this was an indica-
tion that request in last semester of study was 
more appropriate.
Due to great variations in number of laboratory 
test requests found in previous studies in PC, we 
decided to differentiate the study of requests in 
PC and SC (10). Regarding PC, we observed a trend 
profile similar to that of global request trend, 
though more accentuated, with a higher SPC in 
pre- and post-intervention phases. This means 
that requests were increasing and then decreased 
significantly, implying that interventions put in 
place were clearly successful for both tests. Prima-
ry Care concentrated an inappropriate number of 
TPOab and TGab tests, in this case, and we im-
proved this by provided interventions. 
The study of requests for TPOab and TGab tests in 
SC did not show any Joinpoint statistically signifi-
cant. The N of both tests has been relatively stable 
since 2010 and interventions had no effect on N of 
requests. Thus, it could be concluded that SC 
could be more familiar with the handling of these 
tests and aware on recommendations.
The main limitation of our study is that applied 
successful interventions not guarantee that it was 
safe. We thought that interventions were safe from 
point of view that they were more appropriate, 
but we do not have data about indicators that 
confirm this data, such as the number of new cas-
es diagnosed of thyroid disorders or the increase 
of sequelae due to untreated/undiagnosed thy-
roid disorders (11). We thought that it could be the 
object of a new study.
There was a wide range of possible interventions 
to adapt test request and the literature shows that 
their impact can differ. It is difficult to pinpoint the 
most effective interventions. However, it is essen-
tial to dispose electronic laboratory requests and 
to perform multiple interventions simultaneously 
(2). In a recent systematic review, effectiveness of 
different possible interventions to reduce unnec-
essary requests for thyroid tests, including tests 
for TPOab and TGab antibodies was assessed (12). 
General conclusion was that interventions are ef-
fective when request process is modified, because 
clinical guidelines are better applied; but the re-
view does not establish which interventions are 
the most effective because they were rarely re-
ported in the studies. In this sense, our work at-
tempted to make the interventions explicit, in or-
der to make the study as reproducible as possible. 
We believe that methodology we described is a 
highlight of our study, as it contributes to the eval-
uation of request histories of laboratory tests and 
impact of performed interventions.  
One year passes from the end of the semester of 
interventions in November 2016 until the end of 
the study in October 2017 and we thought that it 
was a considerable time to consider our conclu-
sions as valid. Obviously, we expect the trend to 
continue over time as it adapts a jointpoint regres-
sion model. More specifically, recent semester 
data indicate that trend in request for these tests 
still continues to decrease (unpublished data). 
Tests for TPOab would be recommended for the 
diagnosis and to detect a risk factor of autoim-
mune thyroid disease, as well as a risk factor for 
thyroid dysfunction in other situations such as 
pregnancy, certain medications, Down syndrome, 
etc (7). The aim of our interventions was to end 
practice of requests when following-up autoim-
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mune thyroid disease, as previous positive tests 
exist. On the other hand, TGab tests are recom-
mended in cases of differentiated thyroid cancer 
together with determination of thyroglobulin, as 
well as for diagnosing autoimmune thyroid dis-
ease in areas deficient in iodine (7). In areas with 
sufficient iodine, such as context of this study, it is 
not recommended to determine both antibodies 
since patients with negative TPOab tests and de-
tectable TGab rarely have thyroid dysfunction (13). 
Interventions carried out on TGab requests were 
designed to prevent both antibodies from being 
requested simultaneously, by modifying the pro-
files; if both were requested, the objective was to 
cancel the TGab if the TPOab test was detected 
positive first. Due to all these interventions, a neg-
ative slope trend was achieved in the global de-
mand for TPOab and TGab tests with an SPC of - 
45% and - 61%, respectively. Thus, results showed 
that applied intervention enabled change of TPO-
ab and TGab test requests overuse as well as ad-
justing appropriate requests for both test. A key 
setting where the interventions were successful 
was PC, but test request in SC was not modified. 
We recommend that interventions for the correct 
request for TPOab and TGab tests should be fo-
cused on PC.
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